BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8623164)

  • 1. Cardiac allograft vasculopathy. Preferential regulation of endothelial cell-derived mesenchymal growth factors in response to a donor-specific cell-mediated allogeneic response.
    Hosenpud JD; Morris TE; Shipley GD; Mauck KA; Wagner CR
    Transplantation; 1996 Mar; 61(6):939-48. PubMed ID: 8623164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac allograft vasculopathy. Association with cell-mediated but not humoral alloimmunity to donor-specific vascular endothelium.
    Hosenpud JD; Everett JP; Morris TE; Mauck KA; Shipley GD; Wagner CR
    Circulation; 1995 Jul; 92(2):205-11. PubMed ID: 7600652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of human aortic endothelial cell-derived mesenchymal growth factors by allogeneic lymphocytes in vitro. A potential mechanism for cardiac allograft vasculopathy.
    Wagner CR; Morris TE; Shipley GD; Hosenpud JD
    J Clin Invest; 1993 Sep; 92(3):1269-77. PubMed ID: 8376585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of thrombospondin-1 and cardiac allograft vasculopathy in human cardiac allografts.
    Zhao XM; Hu Y; Miller GG; Mitchell RN; Libby P
    Circulation; 2001 Jan; 103(4):525-31. PubMed ID: 11157717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac allograft vasculopathy: IgM antibody responses to donor-specific vascular endothelium.
    Hosenpud JD; Mauck KA; Hogan KB
    Transplantation; 1997 Jun; 63(11):1602-6. PubMed ID: 9197353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal reduction in acute rejection after heart transplantation is not associated with a reduction in cell-mediated responses to donor-specific vascular endothelium.
    Hosenpud JD; Shipley GD; Mauck KA; Morris TE; Wagner CR
    J Heart Lung Transplant; 1995; 14(5):926-37. PubMed ID: 8800729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphism in platelet-derived growth factor and vascular endothelial growth factor are significantly associated with cardiac allograft vasculopathy.
    Tambur AR; Pamboukian S; Costanzo MR; Heroux A
    J Heart Lung Transplant; 2006 Jun; 25(6):690-8. PubMed ID: 16730575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular cell adhesion molecule-1 is induced on vascular endothelia and medial smooth muscle cells in experimental cardiac allograft vasculopathy.
    Ardehali A; Laks H; Drinkwater DC; Ziv E; Drake TA
    Circulation; 1995 Aug; 92(3):450-6. PubMed ID: 7543379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of acidic fibroblast growth factor and full-length platelet-derived growth factor expression in human cardiac allografts. Analysis by PCR, in situ hybridization, and immunohistochemistry.
    Zhao XM; Yeoh TK; Frist WH; Porterfield DL; Miller GG
    Circulation; 1994 Aug; 90(2):677-85. PubMed ID: 7519129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late onset antibody-mediated rejection and endothelial localization of vascular endothelial growth factor are associated with development of cardiac allograft vasculopathy.
    Bayliss J; Bailey M; Leet A; Stein AN; Thomson NM; McLean CA
    Transplantation; 2008 Oct; 86(7):991-7. PubMed ID: 18852667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies against heterogeneous nuclear ribonucleoprotein K in patients with cardiac allograft vasculopathy.
    Acevedo MJ; Caro-Oleas JL; Álvarez-Márquez AJ; Sobrino JM; Lage-Gallé E; Aguilera I; Núñez-Roldán A
    J Heart Lung Transplant; 2011 Sep; 30(9):1051-9. PubMed ID: 21489814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of immune markers in human cardiac allograft recipients and association with coronary artery vasculopathy.
    Poggio ED; Roddy M; Riley J; Clemente M; Hricik DE; Starling R; Young JB; Gus B; Yamani MH; Heeger PS
    J Heart Lung Transplant; 2005 Oct; 24(10):1606-13. PubMed ID: 16210137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of HLA compatibility on the incidence of cardiac allograft vasculopathy after heart transplantation.
    Stempfle HU; Mudra H; Strom C; Angermann CE; Klauss V; Rieber J; Scholz S; Spes C; Uberfuhr P; Theisen K
    Transplant Proc; 1995 Jun; 27(3):1977-8. PubMed ID: 7792857
    [No Abstract]   [Full Text] [Related]  

  • 14. The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response.
    van Loosdregt J; van Oosterhout MF; Bruggink AH; van Wichen DF; van Kuik J; de Koning E; Baan CC; de Jonge N; Gmelig-Meyling FH; de Weger RA
    Circulation; 2006 Oct; 114(15):1599-607. PubMed ID: 17015796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticardiac myosin immunity and chronic allograft vasculopathy in heart transplant recipients.
    Kalache S; Dinavahi R; Pinney S; Mehrotra A; Cunningham MW; Heeger PS
    J Immunol; 2011 Jul; 187(2):1023-30. PubMed ID: 21677143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor A is associated with the subsequent development of moderate or severe cardiac allograft vasculopathy in pediatric heart transplant recipients.
    Daly KP; Stack M; Eisenga MF; Keane JF; Zurakowski D; Blume ED; Briscoe DM
    J Heart Lung Transplant; 2017 Apr; 36(4):434-442. PubMed ID: 27865734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary endothelial dysfunction after heart transplantation predicts allograft vasculopathy and cardiac death.
    Hollenberg SM; Klein LW; Parrillo JE; Scherer M; Burns D; Tamburro P; Oberoi M; Johnson MR; Costanzo MR
    Circulation; 2001 Dec; 104(25):3091-6. PubMed ID: 11748106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenetic mechanisms of cardiac allograft vasculopathy--impact of nitric oxide.
    Koglin J
    Z Kardiol; 2000; 89 Suppl 9():IX/24-7. PubMed ID: 11151787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD34+CD140b+ cells and circulating CXCL12 correlate with the angiographically assessed severity of cardiac allograft vasculopathy.
    Schober A; Hristov M; Kofler S; Forbrig R; Löhr B; Heussen N; Zhe Z; Akhtar S; Schumann U; Krötz F; Leibig M; König A; Kaczmarek I; Reichart B; Klauss V; Weber C; Sohn HY
    Eur Heart J; 2011 Feb; 32(4):476-84. PubMed ID: 21036775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of coronary angiography and risk factors for post-heart-transplant cardiac allograft vasculopathy.
    Sharples LD; Jackson CH; Parameshwar J; Wallwork J; Large SR
    Transplantation; 2003 Aug; 76(4):679-82. PubMed ID: 12973108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.